Catalyst Pharmaceuticals Inc (CPRX) - Financial and Strategic SWOT Analysis Review

September 2021 | 60 pages | ID: CC0C3DA889BEN
GlobalData

Abstracts

Catalyst Pharmaceuticals Inc (CPRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Catalyst Pharmaceuticals Inc (Catalyst) is a biopharmaceutical company that develops and commercializes prescription drugs targeting rare neurological and neuromuscular diseases. The company focuses on specific conditions such as lambert-eaton myasthenic syndrome (LEMS), congenital myasthenic syndromes (CMS), musk-myasthenia gravis (MuSK-MG), type 3 spinal muscular atrophy (SMA) and downbeat nystagmus. Its product portfolio includes Firdapse, a proprietary form of amifampridine phosphate for the treatment of LEMS, CMS, MuSK-MG and SMA. The company operates in the US and through its subsidiary in Ireland. Catalyst is headquartered in Coral Gables, Florida, the US.

Catalyst Pharmaceuticals Inc Key Recent Developments

Aug 16,2021: Catalyst Pharmaceuticals Appoints Mary Coleman as Vice President, Head of Investor Relations
Aug 09,2021: Catalyst Pharmaceuticals Announces Second Quarter 2021 Financial Results and Provides Corporate Update
Jul 06,2021: Catalyst Pharmaceuticals Expands Leadership Team with Appointment of Preethi Sundaram, Ph.D. as Chief Product Development Officer
Jun 29,2021: Catalyst Pharmaceuticals Appoints Pharmaceutical Executive Molly Harper to its Board of Directors
May 10,2021: Catalyst Pharmaceuticals Announces First Quarter 2021 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Catalyst Pharmaceuticals Inc - Key Facts
Catalyst Pharmaceuticals Inc - Key Employees
Catalyst Pharmaceuticals Inc - Key Employee Biographies
Catalyst Pharmaceuticals Inc - Major Products and Services
Catalyst Pharmaceuticals Inc - History
Catalyst Pharmaceuticals Inc - Company Statement
Catalyst Pharmaceuticals Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Catalyst Pharmaceuticals Inc - Business Description
Catalyst Pharmaceuticals Inc - Corporate Strategy
Catalyst Pharmaceuticals Inc - SWOT Analysis
SWOT Analysis - Overview
Catalyst Pharmaceuticals Inc - Strengths
Catalyst Pharmaceuticals Inc - Weaknesses
Catalyst Pharmaceuticals Inc - Opportunities
Catalyst Pharmaceuticals Inc - Threats
Catalyst Pharmaceuticals Inc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Catalyst Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Catalyst Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Catalyst Pharmaceuticals Inc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Aug 16, 2021: Catalyst Pharmaceuticals Appoints Mary Coleman as Vice President, Head of Investor Relations
Aug 09, 2021: Catalyst Pharmaceuticals Announces Second Quarter 2021 Financial Results and Provides Corporate Update
Jul 06, 2021: Catalyst Pharmaceuticals Expands Leadership Team with Appointment of Preethi Sundaram, Ph.D. as Chief Product Development Officer
Jun 29, 2021: Catalyst Pharmaceuticals Appoints Pharmaceutical Executive Molly Harper to its Board of Directors
May 10, 2021: Catalyst Pharmaceuticals Announces First Quarter 2021 Financial Results
Mar 15, 2021: Catalyst Pharmaceuticals Announces Fourth Quarter and Year-End 2020 Financial Results and Provides Corporate Update
Mar 04, 2021: Catalyst Pharmaceuticals to Hold Fourth Quarter and Year-End 2020 Financial Results and Corporate Update Conference Call and Webcast on Tuesday, March 16th, 2021
Feb 22, 2021: Catalyst Pharmaceuticals announces support of Rare Disease Day 2021
Jan 06, 2021: Catalyst Pharmaceuticals announces strategic plan for product portfolio expansion for long-term success and provides corporate update
Nov 09, 2020: Catalyst Pharmaceuticals announces third quarter 2020 financial results and provides business update

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Catalyst Pharmaceuticals Inc, Key Facts
Catalyst Pharmaceuticals Inc, Key Employees
Catalyst Pharmaceuticals Inc, Key Employee Biographies
Catalyst Pharmaceuticals Inc, Major Products and Services
Catalyst Pharmaceuticals Inc, History
Catalyst Pharmaceuticals Inc, Subsidiaries
Catalyst Pharmaceuticals Inc, Key Competitors
Catalyst Pharmaceuticals Inc, Ratios based on current share price
Catalyst Pharmaceuticals Inc, Annual Ratios
Catalyst Pharmaceuticals Inc, Annual Ratios (Cont...1)
Catalyst Pharmaceuticals Inc, Annual Ratios (Cont...2)
Catalyst Pharmaceuticals Inc, Interim Ratios
Catalyst Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Catalyst Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Catalyst Pharmaceuticals Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Catalyst Pharmaceuticals Inc, Performance Chart (2016 - 2020)
Catalyst Pharmaceuticals Inc, Ratio Charts
Catalyst Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Catalyst Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021